Labscoop and LenioBio Announce Strategic Partnership to Enhance Access of Scalable Cell-Free Protein Synthesis Technology Across North America

Setting a New Standard for Rapid Protein Production Spanning Basic Research, Clinical Trials and Biopharma Applications

LITTLE ROCK, AR, UNITED STATES — In a strategic move set to redefine the landscape of protein production across North America, LenioBio GmbH, a life scie nces biotech company pioneering disruptive protein expression technologies, and leading life sciences marketplace, Labscoop LLC, announce a strategic partnership to bring LenioBio’s line of cutting-edge products and services to Labscoop Marketplace users and the North American market more broadly.

LenioBio’s groundbreaking ALiCE® (Almost Living Cell-Free Expression) technology is transforming the way proteins are produced, accelerating protein discovery and development projects. By utilizing the powerful protein production machinery of plant cells to rapidly express proteins through a cell-free reaction, ALiCE® enables the production of even the most complex proteins, including those that have proven impossible to express in other systems.

ALiCE® boasts a proven track record in producing diverse proteins, from novel antibody formats to membrane proteins and other complex targets. LenioBio’s product line supports applications from micro to milligram scale protein production, enabling high-throughput screening, target characterization, and rapid design-make-test-analyze cycles. The scalability of ALiCE® eliminates the need for cell-line development and process optimization, allowing scaled protein production in just days. This breakthrough technology is set to revolutionize protein exploration and development across various fields, from fundamental research to biopharmaceutical innovation.

Labscoop’s deep roots in the life sciences across thousands of organizations in both industry and academia enables ease of ordering, overnight delivery, and exceptional US-based customer support. Labscoop also employs sustainable practices through low-carbon footprint logistics and by utilizing plant-based, recyclable cold chain packaging materials. Collectively, these measures further amplify the key advantages of an unparalleled efficiency, versatility and scalability of the revolutionary ALiCE® platform across North America.

“We are thrilled to partner with Labscoop to bring our ALiCE® technology to a wider audience in North America,” said Malene Linderoth, Chief Commercial Officer of LenioBio: “This collaboration aligns perfectly with our mission to accelerate protein research and biotherapeutic development. By leveraging Labscoop’s extensive marketplace, we can provide researchers and developers with unparalleled access to our innovative protein production solutions, ultimately driving forward scientific advancements.”

Kundan Das, CEO of Labscoop, echoed this sentiment. “Our alliance with LenioBio is a testament to our shared vision of advancing scientific discovery through innovative solutions and superior service. By offering LenioBio’s line of cutting-edge products and services on the Labscoop Marketplace and managing logistics in all key North American markets, we are poised to deliver exceptional value and support to a wide range of customers in academia and industry. This partnership underscores our dedication to facilitating seamless access to the most advanced technologies available.”

This strategic partnership marks a significant milestone in protein production, heralding a new era of collaboration and innovation. Together, Labscoop and LenioBio are set to drive scientific advancement, empower researchers, and contribute to groundbreaking discoveries that will help shape the future of biotech and healthcare. For more information about the partnership and to explore LenioBio’s products, please visit Labscoop.com.

About Labscoop LLC
Labscoop is a technology company building team-centric Marketplace experiences for academic and commercial laboratories. Labs of all sizes from a wide range of industries and organizations utilize Labscoop to streamline ordering workflows and to drive cost savings.

About LenioBio GmbH
LenioBio is a life sciences biotech company, pioneering a disruptive protein expression platform. Using ALiCE® technology enables researchers and biopharma manufacturers to streamline and accelerate their protein discovery, development, and production processes. LenioBio simplifies manufacturing and speeds up the delivery of drugs to the patients.

PRESS CONTACTS
pr@labscoop.com